These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 652444)

  • 1. [Fibrinolytic and anticoagulant treatment in selected cases of glomerulonephritis in children].
    Oknińska A; Ostojska J; Galczak W; Grygalewicz J; Antoszewska A
    Pediatr Pol; 1978 Apr; 53(4):513-22. PubMed ID: 652444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary protein reduction by anticoagulant and fibrinolytic therap- in membranous glomerulonephropathy].
    Kawaguchi N; Seki H; Furukawa K; Okuda S; Kimura I
    Nihon Jinzo Gakkai Shi; 1977 Feb; 19(2):91-8. PubMed ID: 559831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of glomerulonephritis].
    Tojo S
    Nihon Rinsho; 1984 Jun; 42(6):1298-309. PubMed ID: 6481991
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulants and antithrombotics in rapidly progressive glomerulopnehritis in children].
    Vargas R; Alemán P; Santos D
    Bol Med Hosp Infant Mex; 1975; 32(5):803-13. PubMed ID: 1174431
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulant therapy in human renal disease.
    Bergstein JM
    Int J Pediatr Nephrol; 1981 Mar; 2(1):1-8. PubMed ID: 7037668
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 7. Degradation products and the role of coagulation in "persistent" glomerulonephritis.
    Chirawong P; Nanra RS; Kincaid-Smith P
    Ann Intern Med; 1971 Jun; 74(6):853-9. PubMed ID: 4931741
    [No Abstract]   [Full Text] [Related]  

  • 8. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet antiaggregation and anticoagulant drugs in the treatment of proliferative glomerulonephritis in children].
    Genova R; Barbieri U; Cocconcelli P; Boselli F
    Minerva Pediatr; 1979 Jan; 31(2):171-85. PubMed ID: 460074
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations].
    Mikhaĭlova NA; Tartakovskaia AI
    Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current views on anticoagulant and fibrinolytic treatment in coronary arterial disease].
    Wojczuk J
    Wiad Lek; 1971 Apr; 24(8):749-54. PubMed ID: 4252798
    [No Abstract]   [Full Text] [Related]  

  • 12. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some recent advances in the anticoagulant and fibrinolytic therapy of thrombosis].
    Samama M
    Angeiologie; 1967; 20():Suppl:54-8. PubMed ID: 5621508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic and anticoagulant therapy of acute deep venous thrombosis (proceedings)].
    Niessner H; Lechner K; Nowotny C; Thaler E
    Acta Med Austriaca Suppl; 1976; 3():224-5. PubMed ID: 1072589
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with anticoagulant and fibrinolytic therapy in deep vein thrombosis of the lower extremities].
    Pap S; Deli L; Kander Z; Kántor M; Kis E
    Orv Hetil; 1988 Aug; 129(35):1867-70. PubMed ID: 3174122
    [No Abstract]   [Full Text] [Related]  

  • 17. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of therapy on various indices of hemostasis in glomerulonephritis in children].
    Naumova VI; Mustafina SM
    Pediatriia; 1983 Mar; (3):31-4. PubMed ID: 6866628
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of the effectiveness of anticoagulant and fibrinolytic therapy in myocardial infarct].
    Kheĭnonen IM; Makeeva GK; Kholodilina IM
    Klin Med (Mosk); 1969 Jul; 47(7):41-8. PubMed ID: 5385087
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in electroretractographic indices of the blood in patients with thrombophlebitis treated with fibrinolytic and anticoagulant agents].
    Previna AI; Pshukov SI
    Vestn Khir Im I I Grek; 1969 Oct; 103(10):70-4. PubMed ID: 5366654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.